ResMed Total Non-Current Liabilities increased by 0.7% to $941.16M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 12.9%, from $1.08B to $941.16M. Over 4 years (FY 2021 to FY 2025), Total Non-Current Liabilities shows an upward trend with a 6.3% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
High levels indicate significant long-term leverage, which may increase financial risk but also support long-term capital investment.
This is the sum of all financial obligations that are not due within the next twelve months. It provides a view of the c...
Standard metric for assessing long-term solvency and capital structure.
total_noncurrent_liabilities| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $930.68M | $1.08B | $967.84M | $959.20M | $1.05B | $1.05B | $2.21B | $2.02B | $1.86B | $1.72B | $1.66B | $1.41B | $1.10B | $1.12B | $1.04B | $1.08B | $1.19B | $931.59M | $934.38M | $941.16M |
| QoQ Change | — | +15.9% | -10.3% | -0.9% | +9.0% | +0.6% | +109.6% | -8.4% | -7.7% | -7.7% | -3.5% | -14.9% | -22.2% | +2.3% | -7.7% | +4.2% | +9.9% | -21.5% | +0.3% | +0.7% |
| YoY Change | — | — | — | — | +12.4% | -2.5% | +127.9% | +110.6% | +78.2% | +63.5% | -24.8% | -30.1% | -41.1% | -34.7% | -37.5% | -23.5% | +8.2% | -17.1% | -9.8% | -12.9% |